AI system predicts protein fragments that can bind to or inhibit a target
All biological function is dependent on how different proteins interact with each other. Protein-protein interactions ...
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
Chemical process enhances room temperature stability - - Provisional patent applications filed -PURCHASE, N.Y., Feb. 20, 2025 (GLOBE ...
Kymera Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27
About Kymera Therapeutics Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and ...
Biologists discover a new type of control over RNA splicing
RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, ...
unr.edu1d
You’re more complex than a worm, and researchers now believe they know why
Perhaps you’d also like to believe that humans are more complex than a worm that is used precisely for its simplicity. For ...
Monash University1d
Scientists discover how to “switch off” a known driver of prostate and other cancers
In the case of PSKH1, which is a ‘signalling molecule’, the researchers found that when it binds to a protein called ‘Calmodulin’ PSKH1 is “switched on” and when it binds to a protein called ...
ALS News Today1d
Voyager Therapeutics reassesses SOD1-ALS gene therapy program
The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...
Pulmonaryhypertensionnews.com3d
STAT6 protein may have role in PH tied to sleep apnea, study finds
The immune protein STAT6 may be a driver of pulmonary hypertension in people with obstructive sleep apnea, a study in mice ...